Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals to Report First Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, April 18, 2007
Arena Pharmaceuticals to Report First Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, April 18, 2007 SAN DIEGO, April 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report first
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2000 Second Quarter Results
Arena Pharmaceuticals Announces 2000 Second Quarter Results SAN DIEGO, Sept. 6 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported results for the quarter ended June 30, 2000. During the second quarter 2000, the Company reported revenues of $1.3 million versus no revenues for
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2000 Third Quarter Results; Sequential Quarterly Revenue Growth of 79%
Arena Pharmaceuticals Announces 2000 Third Quarter Results; Sequential Quarterly Revenue Growth of 79% SAN DIEGO, Oct. 25 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA - news ) today reported results for the quarter ended September 30, 2000.
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2001 Second Quarter and Six Months Results and Reaffirms Financial Guidance for 2001
Arena Pharmaceuticals Announces 2001 Second Quarter and Six Months Results and Reaffirms Financial Guidance for 2001 SAN DIEGO, Jul 23, 2001 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported revenues of $3.3 million for the quarter ended June 30, 2001, a 158% increase over
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2002 Second Quarter and Six Months Results
Arena Pharmaceuticals Announces 2002 Second Quarter and Six Months Results SAN DIEGO, Jul 23, 2002 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported revenues of $5.8 million for the quarter ended June 30, 2002, a 75% increase over second quarter 2001
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2002 Third Quarter and Nine Months Results
Arena Pharmaceuticals Announces 2002 Third Quarter and Nine Months Results SAN DIEGO, Oct 29, 2002 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported revenues of $3.0 million for the quarter ended September 30, 2002, a 14% decrease over revenues of $3.5
View HTML
Toggle Summary Arena Pharmaceuticals Announces Financial Results For the First Quarter of 2002
Arena Pharmaceuticals Announces Financial Results For the First Quarter of 2002 SAN DIEGO, Apr 24, 2002 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported revenues of $4.2 million for the quarter ended March 31, 2002, versus $5.4 million in revenues for
View HTML
Toggle Summary Arena Pharmaceuticals Announces Financial Results for the First Quarter of 2003
Arena Pharmaceuticals Announces Financial Results for the First Quarter of 2003 SAN DIEGO, Apr 23, 2003 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported revenues of $5.4 million for the quarter ended March 31, 2003, a 27% increase over revenues of $4.2
View HTML
Toggle Summary Arena Pharmaceuticals Announces Financial Results For the Fourth Quarter and Full Year of 2001
Arena Pharmaceuticals Announces Financial Results For the Fourth Quarter and Full Year of 2001 SAN DIEGO, Jan. 17 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported record revenues of $5.9 million for the quarter ended December 31, 2001, a 44% increase over fourth
View HTML
Toggle Summary Arena Pharmaceuticals Announces Financial Results for the Fourth Quarter and Full Year of 2002
Arena Pharmaceuticals Announces Financial Results for the Fourth Quarter and Full Year of 2002 SAN DIEGO, Jan. 20 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported record revenues of $6.4 million for the quarter ended December 31, 2002, a 9% increase over revenues
View HTML